Condensed Consolidated Balance Sheets (As Restated) (Current Period Unaudited) (Parentheticals) - USD ($)		Jun. 30, 2016	Mar. 31, 2016
Cash and cash equivalents		$ 3,969,976	$ 5,345,455	[1]
Allowance for doubtful accounts		355,000	426,000	[2]
Accounts receivable		11,230,664	12,303,128	[1]
Inventories		15,199,716	12,274,104	[1]
Prepaid expenses and other		1,192,794	1,668,004	[1]
Property and Equipment, Net		4,813,305	4,577,774	[1]
Other Assets		291,818	317,528	[1]
Intangible Assets, Net			1,109,112	[1]
Goodwill			275,408	[1]
Accounts payable		8,896,453	7,003,660	[1]
Income tax payable			11,312	[1]
Accrued expenses		8,035,357	6,842,874	[1]
Short-term debt		$ 2,177,827	$ 1,859,300	[1]
Preferred stock, par value (in dollars per share)		$ 1	$ 1	[2]
Preferred stock, authorized (in shares)		50,000	50,000	[2]
Common stock, par value (in dollars per share)		$ 0.25	$ 0.25	[2]
Common stock, authorized (in shares)		4,000,000	4,000,000	[2]
Common stock, issued (in shares)		2,372,527	2,372,527	[2]
Common stock, outstanding (in shares)		2,372,527	2,372,527	[2]
Delphax [Member]
Cash and cash equivalents	[3]	$ 495,668	$ 249,528	[2]
Accounts receivable	[3]	1,460,541	1,433,494	[2]
Inventories	[3]	2,834,609	4,642,298	[2]
Prepaid expenses and other	[3]	665,481	1,034,067	[2]
Property and Equipment, Net	[3]	66,605	625,684	[2]
Other Assets	[3]	0	26,020	[2]
Intangible Assets, Net	[3]	0	1,109,112	[2]
Goodwill	[3]	0	275,408	[2]
Accounts payable	[3]	2,672,207	1,684,802	[2]
Income tax payable	[3]	11,312	11,312	[2]
Accrued expenses	[3]	4,409,633	1,926,340	[2]
Short-term debt	[3]	$ 2,177,827	$ 1,859,300	[2]

[1] Derived from audited financial statements

[2] Derived from audited financial statements

[3] Amounts related to Delphax as of June 30, 2016 and March 31, 2016, respectively